CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous Leukemia.
Li H, Xu S, Quan J, Yung BC, Pang J, Zhou C, Cho YA, Zhang M, Liu S, Muthusamy N, Chan KK, Byrd JC, Lee LJ, Marcucci G, Lee RJ.
Li H, et al. Among authors: xu s.
Mol Pharm. 2015 Jun 1;12(6):2010-8. doi: 10.1021/mp5008212. Epub 2015 Apr 28.
Mol Pharm. 2015.
PMID: 25871632
Free PMC article.